Apricot seeds, like most nuts and seeds are very nutritious. Among the nutrients they contain is one called amygdalin, which is also known as vitamin B17. This attacks cancer cells, and thus can help prevent cancer from breaking out in our bodies.
In 1952, a biochemist named Dr. Ernst Krebb, Jr. in San Francisco decided that cancer was a metabolic reaction to a poor diet, and a missing nutrient from modern man’s diet could be the key to overcoming cancer. His research led to a compound found in over 1200 edible plants throughout nature. That compound is amagdylin.
Amagdylin is found with the highest concentration and necessary enzymes in apricot seeds. A primitive tribe, the Hunzas, were known to consume large amounts of apricot seed kernels. The hard pit had to be broken to get into the soft kernels. There was no incidence of cancer with them at all, ever. And they had long, healthy life spans. Laetrile was created by simply extracting amagdylin from the soft apricot kernels, purifying it and putting it into a concentrated form.
Amagdylin is a nitrioloside. As a nitrioloside, amagdylin resembled the B complex structures, so Dr. Krebb called it B17 since by that time 16 types of B vitamins had been isolated.
Dr. Krebb injected himself with laetrile to ensure there would be no toxic side effects. He conducted further lab animal and culture experiments to conclude that laetrile would be effective in the treatment of cancer. By the way, the FDA standard for drug safety is known as LD 50, LD stands for lethal dose, and the 50 is the percentage threshold of lab animals poisoned to death by the drug tested. As long as the percentage killed is under 50%, FDA will approve it.
Amagdylin contains four substances. Two are glucose; one is benzaldyhide, and one is cyanide. Yes, cyanide and benzaldyhide are poisons if they are released or freed as pure molecules and not bound within other molecular formations. Many foods containing cyanide are safe because the cyanide remains bound and locked as part of another molecule and therefore cannot cause harm.
There is even an enzyme in normal cells to catch any free cyanide molecules and to render them harmless by combining them with sulfur. That enzyme is rhodanese, which catalyzes the reaction and binds any free cyanide to sulfur. By binding the cyanide to sulfur, it is converted to a cyanate which is a neutral substance. Then it is easily passed through the urine with no harm to the normal cells.
But cancer cells are not normal. They contain an enzyme that other cells do not share, beta-glucosidase. This enzyme, virtually exclusive to cancer cells, is considered the “unlocking enzyme” for amagdylin molecules. It releases both the benzaldyhide and the cyanide, creating a toxic synergy beyond their uncombined sum. This is what the cancer cell’s beta-glucosidase enzyme does to self destruct cancer cells.
Amagdylin or laetrile in conjunction with the protective enzymes in healthy cells and the unlocking enzymes in cancer cells is thus able to destroy cancer cells without jeopardizing healthy cells. Chemotherapy, on the other hand, kills a lot of other cells and diminishes one’s immune system while killing an undetermined amount of cancer cells.
Those cancer cells tend to return elsewhere because the patient’s general health was reduced from the pervasive chemo toxins. The cancer industry has declared the bench mark for curing cancer as being cancer free for 5 years. It’s estimated that of those who undergo the AMA big three for curing cancer, surgery, radiation, and chemotherapy, no more than 3% make the 5 year cancer free mark.
But for someone with cancer, it takes a considerable amount of daily B17 consumption to enable the amagdylin to reach the cancer cells with beta-glucosidase. That’s because some of the amagdylin molecules will be neutralized by the normal cells containing rhodanese.
Many practitioners who use laetrile have an 85% cure rate among cancer victims who did not undergo much of the standard cut, burn, and poison that is main-stream – while the cure rate for those who come to laetrile therapy as a last resort after all that conventional medicine could only have a 15% recovery rate. There is a clinic in Mexico that claims a 100 percent cure rate!
A young Brooklyn man, Jason Vale, was imprisoned because he refused to stop telling others on TV and in lectures how he cured himself of cancer using those nasty apricot pit kernels. Jason is a more recent public example of the Medical Mafia’s grip on the legal system regarding B17. Laetrile, which is non toxic, was banned by the FDA in 1971.
Shortly after the 1971 laetrile ban, a practicing physician in San Francisco, Dr. John Richardson, who had been using laetrile successfully on cancer patients, came to his friend G. Edward Griffin, a published investigative journalist, and asked Griffin if he could write up something to help him and others continue using laetrile on their cancer patients.
G. Edward Griffin’s research evolved into his groundbreaking book, World Without Cancer. This book not only explained laetrile and chronicled several cancer cures, but Griffin’s investigative nose led him down the rabbit hole and into the underbelly of the cancer industry’s efforts at keeping alternative cancer cures from the light of day. That’s how he discovered that the Sloane-Kettering Cancer Institute had buried documentation from scientists’ research, which proved laetrile was “highly effective” at curing cancer.
Griffin received those documents himself from a Dr. Ralph Moss, who had been told to cover up that evidence and claim that laetrile was worthless. He refused and left his position as PR manager with Sloane-Kettering. Since that time in 1977, Dr. Ralph Moss has gone on to write or edit several books on cancer cure options. It’s always encouraging to see an insider come out! Someone else filled Dr. Moss’s vacant position and lied the lies about laetrile that filled the medical journals.
Lately, the most prestigious New England Journal of Medicine dropped its standard of not allowing articles contributed to the journal from anyone who was receiving money from Big Pharma, as long as it’s less than 10 grand annually.

